Category: Neuromuscular Blockade

Residual Neuromuscular Blockade: Not Just Relevant to the Anesthesiologist

Rachel C. Wolfe, Pharm.D., M.H.A., BCCCP

Pharmacists are well positioned to advocate for safe management of patients undergoing neuromuscular blockade and reversal and should expand their knowledge on this topic.

Neuromuscular Blockade

Revising Thoughts on Neuromuscular Blocking Reversal Agents

Deborah Wagner, Pharm.D., FASHP

Pharmacy and therapeutics (P&T) committees have the leadership necessary to create balance from the need and want perspective to what is fiscally reasonable. The case of neuromuscular blocker reversal agents fits these criteria uniquely.